Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies

Summary

To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the pharmacokinetics (PK) of spinosad and benzyl alcohol following a single dose of Natroba™ in pediatric subjects 4-16 years of age. These subjects will be a separate population of pediatric subjects.

Timeline

Start

2017-05-02

Primary completion

2018-06-25

Completion

2018-06-25

Drugs

Indications